drugset / Trial / NCT00048061
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will compare the efficacy and safety of different treatment regimens of oral Bonviva tablets in women with post-menopausal osteoporosis. Patients will also receive daily supplementation with vitamin D and calcium. The anticipated time of study treatment is 2+ years, and the target sample size is 500+ individuals.
Timeline
- Start
- 2002-04
- Primary completion
- 2004-12
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibandronate | Other / unclassified | 2.5 mg | Oral |
| Subject | Ibandronate | Other / unclassified | 100 mg | Oral |
| Subject | Ibandronate | Other / unclassified | 150 mg | Oral |